SIBN SI-BONE, Inc.

Nasdaq si-bone.com


$ 17.78 $ 0.50 (2.87 %)    

Monday, 17-Nov-2025 15:46:15 EST
QQQ $ 602.34 $ -5.20 (-0.85 %)
DIA $ 466.18 $ -5.48 (-1.16 %)
SPY $ 664.83 $ -6.26 (-0.93 %)
TLT $ 89.11 $ 0.22 (0.25 %)
GLD $ 370.86 $ -4.31 (-1.15 %)
$ 17.92
$ 17.47
$ 17.69 x 300
$ 17.79 x 62
$ 17.16 - $ 17.80
$ 11.70 - $ 20.05
1,151,964
na
777.57M
$ 0.91
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 11-10-2025 09-30-2025 10-Q
2 08-05-2025 06-30-2025 10-Q
3 05-06-2025 03-31-2025 10-Q
4 02-25-2025 12-31-2024 10-K
5 11-12-2024 09-30-2024 10-Q
6 08-06-2024 06-30-2024 10-Q
7 05-07-2024 03-31-2024 10-Q
8 02-27-2024 12-31-2023 10-K
9 11-07-2023 09-30-2023 10-Q
10 08-08-2023 06-30-2023 10-Q
11 05-02-2023 03-31-2023 10-Q
12 03-02-2023 12-31-2022 10-K
13 11-08-2022 09-30-2022 10-Q
14 08-09-2022 06-30-2022 10-Q
15 05-10-2022 03-31-2022 10-Q
16 03-01-2022 12-31-2021 10-K
17 11-09-2021 09-30-2021 10-Q
18 08-04-2021 06-30-2021 10-Q
19 05-04-2021 03-31-2021 10-Q
20 03-10-2021 12-31-2020 10-K
21 11-03-2020 09-30-2020 10-Q
22 08-04-2020 06-30-2020 10-Q
23 05-05-2020 03-31-2020 10-Q
24 03-11-2020 12-31-2019 10-K
25 11-12-2019 09-30-2019 10-Q
26 08-07-2019 06-30-2019 10-Q
27 05-09-2019 03-31-2019 10-Q
28 03-14-2019 12-31-2018 10-K
29 11-29-2018 09-30-2018 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 si-bone-raises-fy2025-sales-guidance-from-195000m-198000m-to-198000m-200000m-vs-196584m-est

SI-BONE (NASDAQ:SIBN) raises FY2025 sales outlook from $195.000 million-$198.000 million to $198.000 million-$200.000 million v...

 si-bone-q3-eps-011-beats-017-estimate-sales-48656m-beat-46667m-estimate

SI-BONE (NASDAQ:SIBN) reported quarterly losses of $(0.11) per share which beat the analyst consensus estimate of $(0.17) by 36...

 truist-securities-maintains-buy-on-si-bone-lowers-price-target-to-20

Truist Securities analyst David Rescott maintains SI-BONE (NASDAQ:SIBN) with a Buy and lowers the price target from $22 to $20.

 cantor-fitzgerald-reiterates-overweight-on-si-bone-maintains-25-price-target

Cantor Fitzgerald analyst Ross Osborn reiterates SI-BONE (NASDAQ:SIBN) with a Overweight and maintains $25 price target.

 si-bone-raises-fy2025-sales-guidance-from-193500m-197500m-to-195000m-198000m-vs-195834m-est

SI-BONE (NASDAQ:SIBN) raises FY2025 sales outlook from $193.500 million-$197.500 million to $195.000 million-$198.000 million v...

 si-bone-q2-eps-014-beats-019-estimate-sales-48630m-beat-48112m-estimate

SI-BONE (NASDAQ:SIBN) reported quarterly losses of $(0.14) per share which beat the analyst consensus estimate of $(0.19) by 24...

 truist-securities-maintains-buy-on-si-bone-raises-price-target-to-22

Truist Securities analyst Samuel Brodovsky maintains SI-BONE (NASDAQ:SIBN) with a Buy and raises the price target from $20 t...

 cantor-fitzgerald-reiterates-overweight-on-si-bone-maintains-25-price-target

Cantor Fitzgerald analyst Ross Osborn reiterates SI-BONE (NASDAQ:SIBN) with a Overweight and maintains $25 price target.

 needham-reiterates-buy-on-si-bone-maintains-24-price-target

Needham analyst David Saxon reiterates SI-BONE (NASDAQ:SIBN) with a Buy and maintains $24 price target.

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION